| Literature DB >> 35240762 |
Takuya Otani1,2, Hideki Fujii3, Yasuhiko Kawaguchi3, Tetsuo Hayama3, Toshiomi Abe3, Motoi Takahashi3, Keishi Marumo3.
Abstract
BACKGROUND: Treatment of periprosthetic joint infection (PJI) is challenging, generally requiring complete implant removal. However, recently reported treatments involve partial retention of implants because of the severe local and systemic burden on the patients and difficulties in functional preservation. Long-term results should be evaluated because of the risk of residual biofilm on the retained implant and late infection recurrence. We evaluated 6 to 13-year clinical outcomes of two-stage treatment of chronic PJI retaining well-fixed cementless stems.Entities:
Keywords: Antibiotic-loaded acrylic cement (ALAC); Chronic infection; Implant retention; Periprosthetic joint infection (PJI); Total hip arthroplasty (THA); Treatment; Two-stage treatment
Year: 2019 PMID: 35240762 PMCID: PMC8787924 DOI: 10.1186/s42836-019-0002-8
Source DB: PubMed Journal: Arthroplasty ISSN: 2524-7948
Fig. 1a A 65-year-old man developed late infection 3 years after revision THA. b The fully-porous coated long stem was retained and all the infected proximal femur was resected. Articulating cement spacer was made in the acetabular defect. c No signs of recurrence of infection were observed 158 months after the second-stage reconstruction
Fig. 2a A 52-year-old woman developed deep MRSA infection after THA. b The patient was referred to our department after four repeated irrigation and debridement procedures having developed multiple chronic sinus tracts in her thigh. c Hydroxyapatite spacers in addition to articulating cement spacer were used to contain antibiotics in this patient. d No signs of recurrence of infection were observed 94 months after the second-stage reconstruction
Fig. 3Intraoperative findings of the Case 1; Thorough debridement of the proximal femur was performed using a high-speed burr until fresh, clean bone ingrowth was identified circumferentially
Results of two-stage treatment with retention of well-fixed cementless stem
| Authors | No. of patients | Mean F/U (years) | Infection control rate |
|---|---|---|---|
| Anagnostakos et al. [ | 12 | 4.6 | 11/12 (92%) |
| Ekpo et al. [ | 19 | 4 | 17/19 (89%) |
| Faroug et al. [ | 1 | 3.5 | 1/1 (100%) |
| Fukui et al. [ | 5 | 4.2 | 5/5 (100%) |
| Lee et al. [ | 17 | 4 | 15/17 (88%) |
| Otani et al. | 5 | 9.1 | 5/5 (100%) |
Fig. 4Recent trial to reduce the risk of dislocation; A larger (32 mm) diameter cement-on-cement articulating spacer was made for femoral and acetabular sides